Results 151 to 160 of about 168,584 (163)

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial

Lancet, The, 2018
Zhi-wei Lai, Stephen Faraone, Andras Perl   +2 more
exaly  

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

Lancet, The, 2018
Ronald F Van Vollenhoven, George C Tsokos, Peter E Lipsky   +2 more
exaly  

Systemic lupus erythematosus and lupus nephritis

Nature Reviews Drug Discovery, 2014
exaly  

Novel paradigms in systemic lupus erythematosus

Lancet, The, 2019
Thomas Dörner, Richard A Furie
exaly  

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus

Lancet, The, 1996
Michelle A Petri, Ronenn Roubenoff, Jacob Selhub   +2 more
exaly  

DISSEMINATED LUPUS ERYTHEMATOSUS

Medical Journal of Australia, 1955
openaire   +2 more sources

Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies

Nature Reviews Rheumatology, 2019
Joerg Wenzel
exaly  

Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus

Nature Genetics, 2011
Sulaiman M Al-Mayouf, Reem Abdwani, Safiya Albrawi   +2 more
exaly  

Systemic Lupus Erythematosus

Pediatric Annals, 1982
openaire   +2 more sources

Disseminated lupus erythematosus

The American Journal of Medicine, 1959
openaire   +2 more sources